Results for cyclopropylmethyl translation from English to Finnish

Computer translation

Trying to learn how to translate from the human translation examples.

English

Finnish

Info

English

cyclopropylmethyl

Finnish

 

From: Machine Translation
Suggest a better translation
Quality:

Human contributions

From professional translators, enterprises, web pages and freely available translation repositories.

Add a translation

English

Finnish

Info

English

(-)-17(cyclopropylmethyl)-1,14

Finnish

(-) - 17( cyclopropylmethyl) - 1, 14

Last Update: 2012-04-10
Usage Frequency: 2
Quality:

English

product inn· benzoic acid, sodium salt (benzoate)· doxorubicin iron/carbon magnetically targeted microparticles (mtc-dox for injection) · myristolated-peptidyl-recombinant human cd59· mitotane (lysodren 500 mg tablets)· (-)-17(cyclopropylmethyl)-1,14 ß-dihydroxy-4,5 alpha-epoxy-6ß-[n-methyl-trans-3-(3-furyl) acrylamido ] morphinan hydrochloride (nalfurafine) · autologous renal cell tumor vaccine

Finnish

31. 1. 2002 22. 3. 200228. 3. 2002 30. 4. 2002emea 2003sivu 77/90 euroopan komissio lausunto saatu päätöksen päivämäärä28. 3. 2002 30. 4. 200228. 3. 2002 30. 4. 20026. 5. 2002 12. 6. 20026. 5. 2002 12. 6. 20026. 5. 2002 12. 6. 200230. 5. 2002 26. 6. 20023. 7. 2002 30. 7. 20023. 7. 200230. 7. 20023. 7. 2002 30. 7. 20023. 7. 2002 30. 7. 20023. 7. 2002 30. 7. 200224. 7. 2002 11. 9. 2002emea 2003sivu 78/90valmisteen kansainvälinen yleisnimi (inn)doxorubicin iron/carbon magnetically targeted microparticles (mtc-dox for injection)myristolated-peptidyl -recombinant human cd59mitotane (lysodren 500 mg tablets)(-) -17( cyclopropylmethyl) -1, 14 ß-dihydroxy-4, 5 alpha-epoxy -6ß -[ n-methyl-trans-3 -(3-furyl) acrylamido ] morphinan hydrochloride (nalfurafine) autologous renal cell tumor vaccine

Last Update: 2008-03-04
Usage Frequency: 1
Quality:

Warning: This alignment may be wrong.
Please delete it you feel so.

Get a better translation with
7,746,959,062 human contributions

Users are now asking for help:



We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. Learn more. OK